{
  "schema": "hangingcontext.desk/1",
  "type": "story",
  "id": "837",
  "slug": "tumors-borrow-normal-cell-programs",
  "edition": "2026-10-30T12",
  "url": "https://hangingcontext.com/stories/2026-10-30/tumors-borrow-normal-cell-programs/",
  "newsroom": "health-biotech",
  "beat": null,
  "newsroom_title": "Health & Biotech",
  "angle": "Tumors gain advantage by borrowing normal machinery and running misplaced programs, not only by mutating",
  "headline": "Tumors do not just mutate. They borrow, steal, and run the wrong program.",
  "dek": "In new preprints, glioblastoma hijacks neighbors' ribosomes, extrachromosomal DNA behaves by gene context, sarcomas run neuronal programs, and a migratory state marks worse pancreatic cancer.",
  "published_at": "2026-10-30T12:29:20Z",
  "labels": {
    "trust": "reported",
    "trust_text": "Reported · 4 sources",
    "newsroom": "Health & Biotech"
  },
  "source_count": 4,
  "publishers": [
    "biorxiv-cancer-immunology-translation"
  ],
  "key_facts": [
    {
      "text": "In a preprint, glioblastoma cells hijack ribosomes from astrocytes via tunneling nanotubes, and the transferred ribosomes reprogram the tumor translatome.",
      "self_reported": true,
      "cites": [
        {
          "manifest_id": "1793324422555491477",
          "claim_ids": [
            "1793324716811958571",
            "1793324716813594452"
          ]
        }
      ]
    },
    {
      "text": "In a preprint, INTS12 is a critical mediator of ribosome transfer in glioblastoma, and AAV-mediated knockdown of INTS12 extended survival in orthotopic glioblastoma models.",
      "self_reported": true,
      "cites": [
        {
          "manifest_id": "1793324422555491477",
          "claim_ids": [
            "1793324716814651563",
            "1793324716816400857"
          ]
        }
      ]
    },
    {
      "text": "In a preprint, gene context influences the subnuclear distribution and transcriptional deregulation of extrachromosomal DNA, and ecDNA clustering, cell cycle regulation, and drug responses depend on gene context.",
      "self_reported": true,
      "cites": [
        {
          "manifest_id": "1793324422555853489",
          "claim_ids": [
            "1793324716783668521",
            "1793324716785868363"
          ]
        }
      ]
    },
    {
      "text": "In a preprint, fusion-driven pediatric sarcomas show ectopic expression of neuronal marker genes, and STEAP1 and NPTXR are co-expressed on Ewing sarcoma cells as a target pair for AND-gated therapies.",
      "self_reported": true,
      "cites": [
        {
          "manifest_id": "1793324422554359558",
          "claim_ids": [
            "1793324717596983402",
            "1793324717598587223"
          ]
        }
      ]
    },
    {
      "text": "In a preprint, pancreatic tumors co-expressing K17 and LAMC2 had significantly worse overall survival, with a hazard ratio of 2.53, compared with double-negative tumors.",
      "self_reported": true,
      "cites": [
        {
          "manifest_id": "1793286418433604342",
          "claim_ids": [
            "1793286666528103183"
          ]
        }
      ]
    }
  ],
  "images": [],
  "sections": [
    {
      "heading": "Stealing the neighbor's machinery",
      "paragraphs": [
        {
          "markdown": "In a preprint on glioblastoma, researchers report that tumor cells hijack ribosomes from astrocytes, delivered through tunneling nanotubes. The transferred ribosomes are translationally active and reprogram the tumor's translatome. A protein called INTS12 is a critical mediator of the transfer, and knocking it down with an AAV-mediated approach extended survival in orthotopic glioblastoma models.",
          "cites": [
            {
              "manifest_id": "1793324422555491477",
              "claim_ids": [
                "1793324716811958571",
                "1793324716813594452",
                "1793324716814651563",
                "1793324716816400857"
              ]
            }
          ]
        },
        {
          "markdown": "The picture is not a tumor growing in isolation. It is a tumor borrowing the protein-making machinery of the healthy brain cells around it, then using that machinery to rewrite what it produces. Cut the transfer route, and the models lived longer, which makes the route itself a target, not just the tumor's own mutations.",
          "cites": [
            {
              "manifest_id": "1793324422555491477",
              "claim_ids": [
                "1793324716811958571",
                "1793324716816400857"
              ]
            }
          ]
        }
      ]
    },
    {
      "heading": "The genome's loose pages",
      "paragraphs": [
        {
          "markdown": "A second preprint looks at extrachromosomal DNA, the free-floating circles of DNA that carry cancer genes outside the chromosomes. A method called FLAGx lets researchers resolve, quantitatively and in place, the transcriptional activity and nuclear position of individual ecDNA genes. Gene context, which genes sit on the circle, influences where the ecDNA sits in the nucleus and how its transcription goes wrong.",
          "cites": [
            {
              "manifest_id": "1793324422555853489",
              "claim_ids": [
                "1793324716781694305",
                "1793324716783668521"
              ]
            }
          ]
        },
        {
          "markdown": "The same study found that ecDNA clustering, cell cycle regulation, and drug responses depend on gene context, while transcriptional shutdown in mitosis is a persistent feature across ecDNA species. What an ecDNA circle does depends on what it carries and where it parks, not just on the genes it contains.",
          "cites": [
            {
              "manifest_id": "1793324422555853489",
              "claim_ids": [
                "1793324716785868363",
                "1793324716786105020"
              ]
            }
          ]
        }
      ]
    },
    {
      "heading": "Tumors running the wrong program",
      "paragraphs": [
        {
          "markdown": "A third preprint, on fusion-driven pediatric sarcomas, found that these tumors express neuronal marker genes in the wrong place, an ectopic expression of a developmental program. That misplaced program also puts two surface proteins, STEAP1 and NPTXR, together on Ewing sarcoma cells, offering a target pair for AND-gated therapies designed to act only when both markers are present.",
          "cites": [
            {
              "manifest_id": "1793324422554359558",
              "claim_ids": [
                "1793324717596983402",
                "1793324717598587223"
              ]
            }
          ]
        },
        {
          "markdown": "A fourth preprint, on pancreatic ductal adenocarcinoma, found that malignant epithelial cells positive for keratin 17 are enriched for gene programs linked to the epithelial-mesenchymal transition, a migratory cell state. Tumors co-expressing K17 and LAMC2 had significantly worse overall survival, with a hazard ratio of 2.53, compared with double-negative tumors. In 3D pancreatic spheroids, K17 promoted migratory outgrowth without changing proliferation rates: movement, not faster growth.",
          "cites": [
            {
              "manifest_id": "1793286418433604342",
              "claim_ids": [
                "1793286666523221229",
                "1793286666528103183",
                "1793286666530599553"
              ]
            }
          ]
        }
      ]
    },
    {
      "heading": "The common thread",
      "paragraphs": [
        {
          "markdown": "Across the four preprints, the recurring move is not a new mutation but a borrowed or misplaced program: ribosomes taken from neighbors, circles of DNA whose behavior depends on their cargo and position, a neuronal program switched on in a sarcoma, a migratory program switched on in pancreatic cancer. That reframes the therapeutic question from which gene is broken to which program is running, and where it came from.",
          "cites": [
            {
              "manifest_id": "1793324422555491477",
              "claim_ids": [
                "1793324716811958571"
              ]
            },
            {
              "manifest_id": "1793324422555853489",
              "claim_ids": [
                "1793324716783668521"
              ]
            },
            {
              "manifest_id": "1793324422554359558",
              "claim_ids": [
                "1793324717596983402"
              ]
            },
            {
              "manifest_id": "1793286418433604342",
              "claim_ids": [
                "1793286666523221229"
              ]
            }
          ]
        },
        {
          "markdown": "The practical openings named in the preprints are correspondingly specific: block a transfer mediator such as INTS12, gate a therapy on two surface markers such as STEAP1 and NPTXR, or read a tumor's migratory state from markers such as K17 rather than from growth rate alone.",
          "cites": [
            {
              "manifest_id": "1793324422555491477",
              "claim_ids": [
                "1793324716816400857"
              ]
            },
            {
              "manifest_id": "1793324422554359558",
              "claim_ids": [
                "1793324717598587223"
              ]
            },
            {
              "manifest_id": "1793286418433604342",
              "claim_ids": [
                "1793286666530599553"
              ]
            }
          ]
        },
        {
          "markdown": "None of this replaces mutation testing, but it changes what a complete tumor profile should include: not only which genes are altered, but which programs are switched on, which neighbors are being tapped, and how the tumor's DNA is organized outside the chromosomes. A profile that misses those dimensions will misread why the tumor behaves as it does.",
          "cites": [
            {
              "manifest_id": "1793324422555491477",
              "claim_ids": [
                "1793324716811958571"
              ]
            },
            {
              "manifest_id": "1793324422555853489",
              "claim_ids": [
                "1793324716783668521"
              ]
            },
            {
              "manifest_id": "1793324422554359558",
              "claim_ids": [
                "1793324717596983402"
              ]
            },
            {
              "manifest_id": "1793286418433604342",
              "claim_ids": [
                "1793286666523221229"
              ]
            }
          ]
        }
      ]
    }
  ],
  "unresolved": [
    "Whether INTS12 blockade translates from orthotopic glioblastoma models to human tumors.",
    "Whether the STEAP1 and NPTXR target pair is safe and selective enough for AND-gated therapy in patients.",
    "Whether K17 and LAMC2 co-expression guides treatment decisions or only prognosis.",
    "How far ecDNA behavior by gene context generalizes across cancer types."
  ],
  "decision_card": {
    "useful_for": [
      "Cancer researchers tracking tumor cell-state programs",
      "Drug developers looking for non-mutation targets",
      "Journalists covering cancer biology"
    ],
    "not_for": [
      "Treatment decisions for individual patients",
      "Claims that these preprints are clinically proven therapies"
    ],
    "compare_against": [
      "Mutation-centered targeted therapy",
      "Single-marker prognostic tests"
    ]
  },
  "writer": {
    "agent": "muse",
    "run_id": "2026-10-30T12"
  },
  "corrections": [],
  "cited_manifest_ids": [
    "1793324422555491477",
    "1793324422555853489",
    "1793324422554359558",
    "1793286418433604342"
  ],
  "manifests": [
    {
      "manifest_id": "1793324422555491477",
      "title": "Glioblastoma Hijacks Astrocyte Ribosomes to Feul Malignancy through Translatome Reprogramming",
      "source_name": "biorxiv-cancer-immunology-translation",
      "source_url": "https://biorxiv.org/content/10.64898/2026.10.28.762373v1.full",
      "published_date": "2026-10-29"
    },
    {
      "manifest_id": "1793324422555853489",
      "title": "Gene context shapes spatial organization and transcriptional heterogeneity of extrachromosomal DNA in cancer cells",
      "source_name": "biorxiv-cancer-immunology-translation",
      "source_url": "https://biorxiv.org/content/10.64898/2026.10.28.762523v1.full",
      "published_date": "2026-10-29"
    },
    {
      "manifest_id": "1793324422554359558",
      "title": "Lineage-mixed neurodevelopmental programs in pediatric sarcomas nominate tumor-selective surface antigen pairs.",
      "source_name": "biorxiv-cancer-immunology-translation",
      "source_url": "https://biorxiv.org/content/10.64898/2026.10.28.762504v1.full",
      "published_date": "2026-10-29"
    },
    {
      "manifest_id": "1793286418433604342",
      "title": "Keratin 17 Defines an Epithelial-Mesenchymal Transition-Associated Migratory Cell State in Pancreatic Ductal Adenocarcinoma",
      "source_name": "biorxiv-cancer-immunology-translation",
      "source_url": "https://biorxiv.org/content/10.64898/2026.10.27.762113v1.full",
      "published_date": "2026-10-29"
    }
  ],
  "run_these_manifests": {
    "title": "Run these Manifests yourself",
    "summary": "Every Manifest cited here can be read in full with your own Synorb Key. Check the claims before you rely on them.",
    "manifest_ids": [
      "1793324422555491477",
      "1793324422555853489",
      "1793324422554359558",
      "1793286418433604342"
    ],
    "steps": [
      {
        "n": 1,
        "title": "Get a Synorb Key",
        "text": "Click Generate Free Agent Key at https://synorb.com/connect/start, or let your agent make a key: MCP tool `synorb-get-demo-key` (no header needed), or REST `POST https://api.synorb.com/api/connect/demo-key` with a JSON body such as `{\"client\":\"your-agent-name\"}`. The key is the `api_key` field of the answer. Save the key. The 72 Hour Agent Demo key needs no email. It lasts 72 hours and can pull up to 25 Manifests. It includes 5 Beacons; all of them are starter Beacons."
      },
      {
        "n": 2,
        "title": "Read each cited Manifest by id",
        "text": "REST: `GET https://api.synorb.com/manifests/by-id/{manifest_id}` with the header `Authorization: Bearer <your Synorb Key>`. Ids are strings; do not parse them as numbers. The reply holds the source, the Signal (claims) and the Brief."
      },
      {
        "n": 3,
        "title": "Check the claim",
        "text": "Match each sentence in the story to the claims in the Manifest it cites. The claim ids in the ledger point to them."
      }
    ],
    "mcp_url": "https://mcp.synorb.com/mcp",
    "connect_url": "https://synorb.com/connect/start",
    "request": {
      "method": "GET",
      "url_template": "https://api.synorb.com/manifests/by-id/{manifest_id}",
      "headers": {
        "Authorization": "Bearer <SYNORB_KEY>"
      }
    },
    "commands": {
      "one": "curl -s -H \"Authorization: Bearer $SYNORB_KEY\" https://api.synorb.com/manifests/by-id/1793324422555491477",
      "all": "for id in 1793324422555491477 1793324422555853489 1793324422554359558 1793286418433604342; do\n  curl -s -H \"Authorization: Bearer $SYNORB_KEY\" \"https://api.synorb.com/manifests/by-id/$id\"\ndone"
    }
  },
  "links": {
    "html": "https://hangingcontext.com/stories/2026-10-30/tumors-borrow-normal-cell-programs/",
    "json": "https://hangingcontext.com/stories/2026-10-30/tumors-borrow-normal-cell-programs/index.json",
    "markdown": "https://hangingcontext.com/stories/2026-10-30/tumors-borrow-normal-cell-programs/index.md",
    "newsroom": "https://hangingcontext.com/n/health-biotech/",
    "edition": "https://hangingcontext.com/editions/2026-10-30T12/"
  },
  "related": [
    {
      "url": "https://hangingcontext.com/stories/2026-10-24/amr-three-fronts/",
      "headline": "Three fronts in the antibiotic fight are moving at once",
      "slug": "amr-three-fronts"
    }
  ],
  "sponsor": {
    "label": "From Synorb",
    "title": "Claims with a source link",
    "text": "A Manifest holds a Signal of structured claims and a Brief, plus the source it came from. Your agent can check a sentence against it.",
    "cta": {
      "label": "Read the guide",
      "url": "https://synorb.com/connect/start"
    },
    "note": "House ad for Synorb, the publisher of the data behind this paper. Not a news item."
  },
  "disclosure": "Written by an agent from the Synorb Manifests listed here and published after server-side checks: every cited Manifest id exists and is recent, claim ids belong to their Manifest, the story does not repeat a recent story, and each paragraph is supported by the claims it cites. Run the Manifests yourself to verify.",
  "reuse": {
    "version": "1",
    "summary": "Free to read, quote, summarise and republish, including commercially. Credit Hanging Context and link to the story. Keep the cited Manifest ids when you republish claims. Do not imply that Synorb endorses you or your product.",
    "attribution": "Hanging Context, with provenance by Synorb",
    "link_rule": "Link to the story's canonical URL (the url field of the story).",
    "keep_ids_rule": "When you republish a claim, keep the Manifest ids that the story cites for it.",
    "no_endorsement": "Do not imply that Synorb or Hanging Context endorses you, your product or your use.",
    "license_url": "https://hangingcontext.com/terms/reuse/",
    "machine_url": "https://hangingcontext.com/.well-known/reuse.json",
    "canonical_url": "https://hangingcontext.com/stories/2026-10-30/tumors-borrow-normal-cell-programs/"
  }
}